Director/PDMR Shareholding

RNS Number : 4165M
GlaxoSmithKline PLC
27 April 2018
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr Roger Connor

b)

Position/status

President, Global Manufacturing & Supply

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

b)

Nature of the transaction

Transfer of 49,152 Ordinary Shares between accounts.

 

No change in beneficial ownership.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.00

49,152

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2018-04-26

f)

Place of the transaction

 

n/a

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mr Roger Connor

b)

Position/status

President, Global Manufacturing & Supply

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

 

b)

Nature of the transaction

Transfer of 49,152 Ordinary Shares to spouse for nil consideration.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.00

49,152

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2018-04-27

f)

Place of the transaction

 

n/a

 

 

 

 

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Mrs Denise Connor

b)

Position/status

PCA of Mr Roger Connor (President, Global Manufacturing & Supply)

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

 

 

b)

Nature of the transaction

Receipt of 49,152 Ordinary Shares from spouse for nil consideration.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

 

 

£0.00

49,152

 

 

 

 

 

d)

Aggregated information

n/a (single transaction)

Aggregated volume Price

 

e)

Date of the transaction

2018-04-27

f)

Place of the transaction

 

n/a

 

 

 

 

 

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFDLFLVZFFBBE

Companies

GSK (GSK)
UK 100

Latest directors dealings